Source: International Congress 2014 – COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. G. Cosio, J. B. Soriano, M. Calle, J. J. Soler, J. P. De Torres, J. M. Marín, C. Martínez, P. De Lucas, I. Mir, G. Peces-Barba, N. Feu, I. Solanes, I. Alfageme, C. Casanova (Palma de Mallorca, Madrid, Valencia, Pamplona, Zaragoza, Oviedo, Córdoba, Barcelona, Sevilla, Santa Cruz de Tenerife, Spain). Distribution and outcomes of the new Spanish phenotype-based guideline for COPD. Eur Respir J 2014; 44: Suppl. 58, 535

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 What are common COPD symptoms in a real-life setting? The German DACCORD registry Source: International Congress 2014 – COPD markers Year: 2014 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Assessment of the COPD patients’ care: An audit of clinical practice Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Implementation of COPD phenotypes in real life Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Does NICE COPD audit tools affect management of COPD? Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Comparison of modified medical research council scale and COPD assessment test in subjects with COPD Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Distribution of COPD phenotypes according to the Spanish COPD guidelines in clinical practice Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Inhalation technique education and its impact in asthma and COPD Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014